Abstract
Fisher syndrome (FS) is a regional variant of Guillain–Barré syndrome (GBS) characterized by acute ophthalmoplegia, ataxia, and areflexia. It has a male predominant sex difference with a M:F ratio of ~2:1, and 70 % of FS patients have episodes of antecedent respiratory infection. The annual incidence varies geographically and is higher in Far East countries. As a variant of GBS, immunotherapies are sometimes applied to FS, but the efficacies and benefits of these treatments have not been established. The most important diagnostic marker is serum IgG anti-ganglioside GQ1b antibody, which is present in 80–95 % of FS patients. Using this antibody as a nosological marker has revealed a presumed relationship between FS and other conditions, including Bickerstaff brainstem encephalitis. Anti-GQ1b antibody may be actively involved in the pathogenic process of FS. The localization of the GQ1b epitope in the human ocular motor nerves, muscle spindle, and dorsal root ganglia could reasonably explain all of the core clinical features and physiological observations of this disease. GQ1b-mimic oligosaccharide structures have been identified in bacterial lipooligosaccharides, and immunization with these lipooligosaccharides produces anti-GQ1b antibodies. Siglec-7, a sialic acid-binding Ig-like lectin expressed on monocytes and macrophages, strongly binds to GQ1b and may be involved in antigen-presentation and the induction of anti-GQ1b antibody.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255:57–65.
Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677–9.
Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–7.
Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996;39:668–72.
Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999;22:1071–4.
Mori M, Kuwabara S, Koga M, Asahina M, Ogawara K, Hattori T, Yuki N. IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiatry. 1999;67:668–70.
Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J Neurol Sci. 1993;118:83–7.
Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci. 2009;50:3226–32. doi:10.1167/iovs.08-3333.
Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110:100–6.
Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand. 1994;89:287–92.
Lolekha P, Phanthumchinda K. Miller-Fisher syndrome at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2009;92:471–7.
Zhang G, Li Q, Zhang R, Wei X, Wang J, Qin X. Subtypes and prognosis of Guillain-Barré syndrome in southwest China. PLoS One. 2015;10:e0133520. doi:10.1371/journal.pone.0133520. eCollection 2015.
Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int. 2010;52:13–9. doi:10.1111/j.1442-200X.2009.02951.x.
Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997;63:494–500.
Yuan CL, Wang YJ, Tsai CP. Miller fisher syndrome: a hospital-based retrospective study. Eur Neurol. 2000;44:79–85.
Tsuboi H, Sugeno N, Tateyama M, Nakashima I, Hasegawa T, Kuroda H, Kaneko K, Kobayashi M, Ishigaki A, Fujimori J, Aoki M. Retrospective analysis of Guillain-Barré syndrome and Fisher syndrome after the great east Japan earthquake. Brain Behav. 2014;4:595–7. doi:10.1002/brb3.234.
Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–6.
Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, Sonoo M, Takada K, Japanese GBS Study Group. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry. 2015;86:110–4. doi:10.1136/jnnp-2013-306509.Epub2013Nov22.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33. doi:10.1159/000324710.
Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992;12:57–63.
Mori M, Kuwabara S, Yuki N. Fisher syndrome: clinical features, immunopathogenesis and management. Expert Rev Neurother. 2012;12:39–51. doi:10.1586/ern.11.182.
Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005;64:1605–11.
Arányi Z, Kovács T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol. 2012;19:15–20. doi:10.1111/j.1468-1331.2011.03445.x. e1-3.
Susuki K, Yuki N, Muramatsu M, Hirata K. Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol. 2000;247:652–3.
Smith J, Clarke L, Severn P, Boyce R. Unilateral external ophthalmoplegia in Miller Fisher syndrome: case report. BMC Ophthalmol. 2007;7:7.
Toshniwal P. Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol. 1987;234:353–8.
Colding-Jørgensen E, Vissing J. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand. 2001;103:259–60.
Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome, Contemporary neurology series 34. Philadelphia: F.A.Davis; 1991.
Koga M, Kusunoki S, Kaida K, Uehara R, Nakamura Y, Kohriyama T, Kanda T. Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry. 2012;83:1210–5. doi:10.1136/jnnp-2012-303060.
Al-Din AN, Anderson M, Bickerstaff ER, Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982;105:481–95.
Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, Yuki N. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255:674–82. doi:10.1007/s00415-008-0775-0.
Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, Kamakura K, Kusunoki S. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes. J Neurol Neurosurg Psychiatry. 2008;79:1148–52. doi:10.1136/jnnp.2007.142950.
Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004;148:200–5.
Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain. 1988;111:95–114.
Sauron B, Bouche P, Cathala HP, Chain F, Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology. 1984;34:953–6.
Dachy B, Deltenre P, Deconinck N, Dan B. The H reflex as a diagnostic tool for Miller Fisher syndrome in pediatric patients. J Clin Neurosci. 2010;17:410–1. doi:10.1016/j.jocn.2009.06.014.
Sekiguchi Y, Misawa S, Shibuya K, Mitsuma S, Hirano S, Ohmori S, Koga S, Iwai Y, Beppu M, Kuwabara S. Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents. Clin Neurophysiol. 2013;124:1465–9. doi:10.1016/j.clinph.2013.01.020.
Nagaoka U, Kato T, Kurita K, Arawaka S, Hosoya T, Yuki N, Shikama Y, Yamaguchi K, Sasaki H. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996;47:1601–2.
Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol. 1998;126:322–4.
Shibata A, Hosoya T, Kato T, Yuki N, Nagaoka U, Adachi M, Haku T, Yamaguchi K. Abducens nerve enhancement in acute ophthalmoparesis. Radiat Med. 1998;16:375–7.
Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70:50–5.
Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612. doi:10.1016/j.vaccine.2010.06.003.
Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes – new diagnostic classification. Nat Rev Neurol. 2014;10:537–44. doi:10.1038/nrneurol.2014.138.
Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007;68:1144–6.
Overell JR, Hsieh ST, Odaka M, Yuki N, Willison HJ. Treatment for Fisher syndrome, Bickerstaff’s brainstem encephalitis and related disorders. Cochrane Database Syst Rev. 2007;24:CD004761.
Kaida K, Kusunoki S, Kanzaki M, Kamakura K, Motoyoshi K, Kanazawa I. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology. 2004;62:821–4.
Chida K, Nomura H, Konno H, Takase S, Itoyama Y. Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci. 1999;165:139–43.
Neshige S, Yoshimoto T, Takeshima S, Himeno T, Shimoe Y, Takamatsu K, Kuriyama M. Clinical analyses of recurrence in Guillain-Barré syndrome and Fisher syndrome. Rinsho Shinkeigaku. 2014;54:577–80. Japanese.
Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9. doi:10.1136/jnnp.2008.156463.
Grand’Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain. 1992;115:1093–106.
Heckmann JG, Dütsch M. Recurrent Miller Fisher syndrome: clinical and laboratory features. Eur J Neurol. 2012;19:944–54. doi:10.1111/j.1468-1331.2011.03584.x.
Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol. 1994;50:159–65.
Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol. 2012;259:1366–74. doi:10.1007/s00415-011-6360-y.
Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997;745:32–6.
Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, Yuki N. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol. 1999;45:533–6.
Harper AA, Lawson SN. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. J Physiol. 1985;359:31–46.
Lee KH, Chung K, Chung JM, Coggeshall RE. Correlation of cell body size, axon size, and signal conduction velocity for individually labelled dorsal root ganglion cells in the cat. J Comp Neurol. 1986;243:335–46.
Houliston RS, Koga M, Li J, Jarrell HC, Richards JC, Vitiazeva V, Schweda EK, Yuki N, Gilbert M. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry. 2007;46:8164–71.
Goodyear CS, O’Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999;104:697–708. Erratum in: J Clin Invest. 1999;104:1771.
Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meché FG, van Doorn PA. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Infect Immun. 2001;69:2462–9.
Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 2002;277:327–37.
Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology. 2005;65:1376–81.
Chiba A, Kusunoki S, Kuwata S, Juji T, Shibata Y, Kanazawa I. HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome. J Neuroimmunol. 1995;61:85–8.
Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N. Ganglioside binding pattern of CD33-related siglecs. Bioorg Med Chem Lett. 2003;13:675–8.
Avril T, Wagner ER, Willison HJ, Crocker PR. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun. 2006;74:4133–41.
Attrill H, Imamura A, Sharma RS, Kiso M, Crocker PR, van Aalten DM. Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J Biol Chem. 2006;281:32774–83.
Heikema AP, Jacobs BC, Horst-Kreft D, Huizinga R, Kuijf ML, Endtz HP, Samsom JN, van Wamel WJ. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome. Clin Microbiol Infect. 2013;19:E106–12. doi:10.1111/1469-0691.12073.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Chiba, A. (2016). Fisher Syndrome. In: Kusunoki, S. (eds) Neuroimmunological Diseases. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55594-0_11
Download citation
DOI: https://doi.org/10.1007/978-4-431-55594-0_11
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55593-3
Online ISBN: 978-4-431-55594-0
eBook Packages: MedicineMedicine (R0)